One study by Carola Torazza and her team at the University of Genoa has shed light on a promising avenue for treating Amyotrophic Lateral Sclerosis (ALS) by targeting a specific receptor in , known as metabotropic glutamate receptor type 5 (mGluR5). Published on July 27, 2023, in the journal …
A study by Aradhana Sachdev and colleagues, published on April 23, 2024, in the Proceedings of the National Academy of Sciences of the United States of America, sheds light on potential genetic interventions for conditions linked to the C9orf72 , a major contributor to amyotrophic lateral sclerosis (ALS) …
One study by Ton Fang and colleagues from King's College London has provided valuable insights into how the medication riluzole affects survival in patients with amyotrophic lateral sclerosis (ALS). Published in The Lancet Neurology in May 2018, this research analyzed data from a previous clinical trial to determine at which …
A study by Francis R. Willett and colleagues, published in August 2023 in the journal Nature, explores a groundbreaking speech neuroprosthesis that could significantly enhance communication for individuals with amyotrophic lateral sclerosis (ALS) and other conditions that impair speech. Conducted at the Howard Hughes Medical Institute at Stanford University, …
One study published in JAMA Neurology has found a potential connection between dietary intake of omega-3 polyunsaturated fatty acids (PUFAs) and a reduced risk of developing amyotrophic lateral sclerosis (ALS). The research, led by Kathryn C. Fitzgerald and colleagues from the Department of Nutrition at Harvard School of Public Health, …
A study by Shravan Gowrishankar and colleagues, published in PloS One in 2024, has provided valuable insights into the use of immunosuppression in stem clinical trials, particularly for conditions like amyotrophic lateral sclerosis (ALS). Conducted by researchers from the Department of ENT at Cambridge University Hospitals in the United …
A study published in the International Journal of Molecular Sciences on February 6, 2023, by Andrea Tarozzi and colleagues from the Department for Life Quality Studies at the University of Bologna, investigates various strategies to protect the nervous system from damage caused by neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). …
A study published in Scientific Reports on May 18, 2024, by Zhao Li and colleagues from the College of Sport Science at Sungkyunkwan University, has shed light on the effectiveness of various non-drug treatments for individuals living with amyotrophic lateral sclerosis (ALS). This systematic review and network meta-analysis examined five …
A study published in Frontiers in Neurology by Jianghua Cheng and colleagues from the Department of Rehabilitation at South China Hospital, Shenzhen University, has explored the impact of rehabilitation therapy on patients with amyotrophic lateral sclerosis (ALS). The research, published in 2024, aimed to evaluate how rehabilitation can improve global …
A study by Zhaoyi Jing and colleagues from Shandong University of Traditional Chinese Medicine, published on June 21, 2024, in the journal Medicine, has investigated the relationship between dietary habits and the risk of developing amyotrophic lateral sclerosis (ALS). This research utilized a method called Mendelian randomization to better …